IL28B POLYMORPHISM AND KINETICS OF ANTIVIRAL ACTIVITY FOR ANA598 IN COMBINATION WITH PEGYLATED INTERFERON α2A PLUS RIBAVIRIN IN TREATMENT-NAiVE GENOTYPE-1 CHRONIC HCV PATIENTS

被引：0
|
作者：
Muir, Andrew J. [1 ]
Lawitz, Eric [2 ]
Rodriguez-Torres, Maribel
Rustgi, Vinod K. [3 ]
Hassanein, Tarek [4 ]
Appleman, James R. [5 ]
Crowley, Constance A. [5 ]
Freddo, James L. [5 ]
McHutchison, John G. [1 ]
机构：
[1] Duke Univ, Med Ctr, DCRI, Durham, NC USA
[2] Alamo Med Res, San Antonio, TX USA
[3] Metropolitan Res, Fairfax, VA USA
[4] SCTI Res Fdn, Ctr Liver, San Clemente, CA USA
[5] Anadys Pharmaceut Inc, San Diego, CA USA
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1852
引用
收藏
页码：1200A / 1200A
页数：1
相关论文
共 50 条
  • [31] IDX184 in combination with pegylated interferon-α2a and ribavirin for 2 weeks in treatment-naive patients with chronic hepatitis C
    Lalezari, Jacob
    Box, Terry
    O'Riordan, William
    Mehra, Purvi
    Tuan Nguyen
    Poordad, Fred
    DeJesus, Edwin
    Kwo, Paul
    Godofsky, Eliot
    Lawrence, Shannon
    Dubuc-Patrick, Gloria
    Chen, Jie
    McCarville, Joseph
    Pietropaolo, Keith
    Zhou, Xiao-Jian
    Sullivan-Bolyai, John
    Mayers, Douglas
    ANTIVIRAL THERAPY, 2013, 18 (06) : 755 - 764
  • [32] Randomized Controlled Trial of Pegylated Interferon-Alpha 2a and Ribavirin in Patients With Treatment-NaiVE Chronic Hepatitis C Genotype 6
    Lam, Khoa D.
    Trinh, Huy N.
    Do, Son T.
    Nguyen, Thuan T.
    Garcia, Ruel T.
    Nguyen, Tuan
    Phan, Quang Q.
    Nguyen, Huy A.
    Nguyen, Khanh K.
    Nguyen, Long H.
    Nguyen, Mindie H.
    GASTROENTEROLOGY, 2010, 138 (05) : S783 - S783
  • [33] Daclatasvir plus asunaprevir plus beclabuvir ± ribavirin for chronic HCV genotype 1-infected treatment-naive patients
    Everson, Gregory T.
    Sims, Karen D.
    Thuluvath, Paul J.
    Lawitz, Eric
    Hassanein, Tarek
    Rodriguez-Torres, Maribel
    Desta, Tadesse
    Hawkins, Trevor
    Levin, James M.
    Hinestrosa, Federico
    Rustgi, Vinod
    Schwartz, Howard
    Younossi, Zobair
    Webster, Lynn
    Gitlin, Norman
    Eley, Timothy
    Huang, Shu-Pang
    McPhee, Fiona
    Grasela, Dennis M.
    Gardiner, David F.
    LIVER INTERNATIONAL, 2016, 36 (02) : 189 - 197
  • [34] Pegylated IFN-α2b plus ribavirin for treatment-naive patients coinfected with HCV and HIV
    Mallolas, Josep
    Laguno, Montserrat
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2008, 6 (03) : 281 - 289
  • [35] Association of IL28B genotype and viral response of hepatitis C virus genotype 2 to interferon plus ribavirin combination therapy
    Akuta, Norio
    Suzuki, Fumitaka
    Seko, Yuya
    Kawamura, Yusuke
    Sezaki, Hitomi
    Suzuki, Yoshiyuki
    Hosaka, Tetsuya
    Kobayashi, Masahiro
    Kobayashi, Mariko
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kumada, Hiromitsu
    JOURNAL OF MEDICAL VIROLOGY, 2012, 84 (10) : 1593 - 1599
  • [36] Simeprevir in combination with pegylated interferon-α and ribavirin in the treatment of naive patients with genotype 1 chronic hepatitis C
    Burnevich, E. Z.
    TERAPEVTICHESKII ARKHIV, 2014, 86 (11) : 105 - 114
  • [37] VIRAL SUPPRESSION AT WEEK 4 EXCEEDS THE IL28B SNP FOR PREDICTING SVR IN PEGYLATED INTERFERON PLUS RIBAVIRIN COMBINATION THERAPY OF GENOTYPE 1 INFECTED PATIENTS WITH CHRONIC HEPATITIS C
    Oze, Tsugiko
    Hiramatsu, Naoki
    Yakushijin, Takayuki
    Doi, Yoshinori
    Ogawa, Hiroyuki
    Hagiwara, Hideki
    Mita, Eiji
    Kaneko, Akira
    Katayama, Kazuhiro
    Hijioka, Taizo
    Tamura, Shinji
    Yoshihara, Harumasa
    Inoue, Atsuo
    Imai, Yasuharu
    Hayashi, Eijirou
    Hosui, Atsushi
    Miyagi, Takuya
    Yoshida, Yuichi
    Tatsumi, Tomohide
    Kiso, Shinichi
    Kanto, Tatsuya
    Kasahara, Akinori
    Hayashi, Norio
    Takehara, Tetsuo
    HEPATOLOGY, 2011, 54 : 852A - 853A
  • [38] Randomized Controlled Trial of Pegylated Interferon-Alfa 2a and Ribavirin in Treatment-Naive Chronic Hepatitis C Genotype 6
    Lam, Khoa D.
    Trinh, Huy N.
    Do, Son T.
    Nguyen, Thuan T.
    Garcia, Ruel T.
    Nguyen, Tuan
    Phan, Quang Q.
    Nguyen, Huy A.
    Nguyen, Khanh K.
    Nguyen, Long H.
    Nguyen, Mindie H.
    HEPATOLOGY, 2010, 52 (05) : 1573 - 1580
  • [39] IMPACT OF BASELINE VARIABLES ON RESPONSE TO FALDAPREVIR PLUS PEGYLATED INTERFERON α-2a AND RIBAVIRIN IN PATIENTS WITH HIV/HCV GENOTYPE-1 COINFECTION IN A PHASE III TRIAL
    Tural, C.
    Rockstroh, J. K.
    Nelson, M.
    Bhagani, S.
    Ingiliz, P.
    Soriano, V.
    Nunez, M.
    Valantin, M. -A.
    Valdez Madruga, J.
    Rauch, A.
    Furtado, J.
    Battegay, M.
    Stern, J. O.
    Quinson, A. -M.
    Boecher, W.
    Vinisko, R.
    Manero, M.
    Dieterich, D.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S469 - S469
  • [40] Pegylated Interferon-α-2a plus Ribavirin for Treatment-Naive Asian Patients with Hepatitis C Virus Genotype 1 Infection: A Multicenter, Randomized Controlled Trial
    Liu, Chen-Hua
    Liu, Chun-Jen
    Lin, Chih-Lin
    Liang, Cheng-Chao
    Hsu, Shih-Jer
    Yang, Sheng-Shun
    Hsu, Ching-Sheng
    Tseng, Tai-Chung
    Wang, Chia-Chi
    Lai, Ming-Yang
    Chen, Jun-Herng
    Chen, Pei-Jer
    Chen, Ding-Shinn
    Kao, Jia-Horng
    CLINICAL INFECTIOUS DISEASES, 2008, 47 (10) : 1260 - 1269
12345